Liquidia Corp (LQDA): Rasio rega marang pendapatan
The use of the PRINT system for the precise synthesis of drug microparticles drives the P/S ratio chronology on the GURU.Markets chart, where 8.30 serves as the final level marker for Liquidia Corporation (LQDA). Demand for orphan drugs makes the business resilient to economic downturns; however, protracted patent litigation and regulatory barriers exert significant pressure on the pace of commercialization.
Rincian analitis perusahaan liquidia.com (LQDA)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Liquidia Corporation|LQDA - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Liquidia Corporation|LQDA - Gunggung utang perusahaan|Rasio utang marang nilai buku Liquidia Inc.|LQDA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Liquidia|Rasio cepet liquidia.com
- data bathi resik lan rasio valuasi:
LQDA - Penghasilan resik|Penghasilan resik sing dikarepake Liquidia Corporation|LQDA - Pangali P/E|Prakiraan rega marang bathi Liquidia Inc.|LQDA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Liquidia|LQDA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Liquidia|LQDA - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan liquidia.com|LQDA - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Liquidia Corporation
- data total pendapatan lan volume dodolan:
Analisis umum perusahaan:Liquidia (LQDA)
The P/S ratio determines the market value of one unit of annual turnover, allowing for an assessment of the premium paid for a business relative to its ability to generate revenue. By analyzing the P/S of Liquidia Corporation (LQDA), an investor can gauge market expectations for the commercialization of its inhalation systems, where the indicator's trend reflects market confidence in the success of its proprietary drugs for pulmonary hypertension therapy.
Perusahaan pesaing
HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|MENS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Rasio rega marang pendapatan|Perrigo Company PLC - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan alvotech.com|Multiplikator P/S Galapagos Corp|Rasio rega marang pendapatan ANI Pharma (ANIP)|Multiplikator P/S MannKind Corporation (MNKD)|Rasio rega marang pendapatan Amphastar Pharmaceuticals Inc AMPH|Multiplikator P/S Pacira PCRX|ARS Pharmaceuticals Inc - Multiplikator P/S|TBPH - Multiplikator P/S|AQST (Aquestive Therapeutics) - Kapitalisasi marang pendapatan|scPharmaceuticals, Inc. (SCPH) - Multiplikator P/S|Kapitalisasi marang pendapatan TECX|Multiplikator P/S Tonix Pharma|Kapitalisasi marang pendapatan SXTC (SXT Pharmaceuticals)|EPRX: Rasio rega marang dodolan|BioHarvest Sciences - Kapitalisasi marang pendapatan|EXOZ: Rasio kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|ENTX: Rasio rega marang pendapatan|HYFT: Multiplikator P/S|Kapitalisasi marang pendapatan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Multiplikator P/S|Multiplikator P/S quantumbiopharma.com|Multiplikator P/S FGEN|Kapitalisasi marang pendapatan Telomir Pharmaceuticals, Inc. TELO|Multiplikator P/S RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Rasio rega marang dodolan|RLYB: Kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Kapitalisasi marang pendapatan|Pulmatrix Inc (PULM) - Rasio rega marang pendapatan|PTHL: Kapitalisasi marang volume dodolan|APM (Aptorum Group Ltd) - Multiplikator P/S|Lyra Therapeutics Inc (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Kapitalisasi marang volume dodolan TNFA|cbdMD, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|Altamira Therapeutics Ltd. - Multiplikator P/S|LIPO: Rasio rega marang pendapatan|OPTN: Multiplikator P/S|Rasio rega marang dodolan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Multiplikator P/S|PTPI (Petros Pharmaceuticals Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)
